SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06054035 |
|
Recruitment Status :
Recruiting
First Posted : September 26, 2023
Last Update Posted : May 14, 2024
|
Sponsor:
University Hospital Tuebingen
Collaborators:
German Federal Ministry of Education and Research
German Center for Diabetes Research
AstraZeneca
Information provided by (Responsible Party):
University Hospital Tuebingen
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 31, 2026 |
| Estimated Study Completion Date : | December 31, 2026 |